Epidermal grafting for leukoderma resulting from 1064-nm quality-switched neodymium-doped yttrium aluminium garnet laser toning

Int Wound J. 2018 Dec;15(6):1045-1048. doi: 10.1111/iwj.12953. Epub 2018 Jul 16.

Abstract

Leukoderma secondary to Q-switched 1064-nm neodymium-doped yttrium aluminium garnet laser is usually refractory to treatment. The pathogenesis was cumulative phototoxic damage to melanocytes and eventually resulted in melanocytopenia. Wood's light or UV imaging can help observe early leukoderma before it becomes apparent clinically and determine the degree of melanocytopenia before conducting a biopsy. NB-UVB phototherapy and 308-nm excimer laser can potentially worsen the pre-existing melasma lesions and may not be effective if the lesions have already become melanocytopenic. Epidermal grafting can replenish the hypopigmented area with melanocytes without worsening melasma.

Keywords: Wood's lamp; epidermal grafting; laser toning; leukoderma; melasma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Lasers, Solid-State / adverse effects*
  • Low-Level Light Therapy / adverse effects*
  • Melanocytes / radiation effects*
  • Melanosis / etiology
  • Melanosis / surgery
  • Neodymium / adverse effects*
  • Nevus, Halo / surgery*
  • Skin Transplantation / methods*
  • Treatment Outcome
  • Yttrium / adverse effects*

Substances

  • Neodymium
  • Yttrium